Proteasome inhibitor MG132 inhibits the proliferation and promotes the cisplatin-induced apoptosis of human esophageal squamous cell carcinoma cells.
about
Cell fate determination in cisplatin resistance and chemosensitizationA 3 base pair deletion in TBX1 leads to reduced protein expression and transcriptional activity.Synergistic effects of combining proteasome inhibitors with chemotherapeutic drugs in lung cancer cells.Positioning of proteasome inhibitors in therapy of solid malignancies.ERK is a negative feedback regulator for IFN-γ/STAT1 signaling by promoting STAT1 ubiquitination.
P2860
Proteasome inhibitor MG132 inhibits the proliferation and promotes the cisplatin-induced apoptosis of human esophageal squamous cell carcinoma cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Proteasome inhibitor MG132 inh ...... squamous cell carcinoma cells.
@ast
Proteasome inhibitor MG132 inh ...... squamous cell carcinoma cells.
@en
type
label
Proteasome inhibitor MG132 inh ...... squamous cell carcinoma cells.
@ast
Proteasome inhibitor MG132 inh ...... squamous cell carcinoma cells.
@en
prefLabel
Proteasome inhibitor MG132 inh ...... squamous cell carcinoma cells.
@ast
Proteasome inhibitor MG132 inh ...... squamous cell carcinoma cells.
@en
P2093
P2860
P356
P1476
Proteasome inhibitor MG132 inh ...... squamous cell carcinoma cells.
@en
P2093
Chunyang Zhang
Dengyan Zhu
Donglei Liu
Fengbiao Wen
Lifeng Dang
Xiangnan Li
P2860
P304
P356
10.3892/IJMM.2014.1678
P577
2014-02-27T00:00:00Z